Gvoke Kit Injection, Solution
Product Images NDC 72065-140

Product Visual Gallery

This gallery contains 67 technical images submitted to the FDA as part of the official labeling for Gvoke Kit (NDC 72065-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xeris Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72065 120 11 Ai Pouch 0.5mg

Gvoke is a glucagon injection, designed for low blood sugar emergency. It contains a Single-Dose Autodnjector that can be used in three easy steps: prepare, inject, and assist. The injection can be administered in the abdomen or outer thigh. After the injection, the pen should be put in a safe place and disposed of into an FDA cleared sharps container. In case of emergency, medical help should be called.*

FDA Label Image

72065 121 11 Ai Pouch 1mg

Gvoke HypoPen is an FDA cleared auto-injector for low blood sugar emergencies. The pen delivers 1mg of medicine per 0.2mL and comes in a single pack. The injection process involves tearing the pouch, exposing the skin, pushing down on the skin for five seconds, and placing the used pen in a safe place until it can be disposed of correctly. The pen has a red cap that must be removed, and the patient must wait for the window to turn red before calling emergency medical assistance.*

FDA Label Image

72065 130 11 Pfs Pouch 0.5mg

Gvoke is a pre-filled syringe used to treat low blood sugar emergency. The syringe contains glucagon injection, and the instructions on how to use it are provided on the packaging. The injection is administered by injecting it into the abdomen or outer thighs, and the patient is advised to seek medical assistance. After use, the used syringe should be placed in a safe place until it can be disposed of in an FDA cleared sharps container.*

FDA Label Image

72065 131 11 Pfs Pouch 1mg

Gvoke’ PFS is a glucagon injection for low blood sugar emergency situations. The packaging contains a syringe with a 1mg per 0.2 mL dose. To prepare, tear open the pouch, remove the syringe, and choose an injection site (either the lower abdomen, outer thighs, or outer upper arm). Pinch the skin and insert the needle at a 90 degree angle to inject the glucagon. After injection, turn the patient on their side and seek emergency medical help. The syringe has a viewing window and finger flange, and the needle cap should be pulled off without removing air bubbles.*

FDA Label Image

Ai 0.5 mg 1 Pack Carton Label

Gvoke HypoPen is a single-dose auto-injector containing 0.5mg per 0.1mL of glucagon injection for subcutaneous use in emergency situations of low blood sugar. It contains 1 injector and should be used according to the instructions provided. The auto-injector should be stored in a cool and dry place and should be disposed of properly. For more information, visit www.GvokeHypoPen.com. The text also provides step-by-step instructions for preparing and injecting the medication along with assistance.*

FDA Label Image

Ai 0.5 mg 2 Pack Carton Label

Gvoke HypoPen is a single-dose auto-injector containing 0.5 mg per 0.1mL of glucagon injection that is used in low blood sugar emergencies. The package contains two single-dose auto-injectors and must be stored at controlled room temperature between 20° and 25°C. The glucagon injection is for subcutaneous use only and for more information call the manufacturer. The back panel of the package provides quick guide instructions for use.*

FDA Label Image

Ai 0.5 mg Device Label

The text is a description of a medication called "Gvoke HypoPen' (glucagon injection)", which is a single-dose auto-injector with 0.5mg per 0.1mL concentration for subcutaneous use only. The NDC (National Drug Code) number for this medication is 72065-120-11, and it is manufactured by a company called "Pyramid Laboratories Inc." located in Chicago, Illinois.*

FDA Label Image

Ai 0.5 mg Pouch Label

Gvoke HypoPen is a glucagon injection used for low blood sugar emergency situations. It is a single-dose autoinjector contained in a sealed pouch and can only be used subcutaneously. It should be stored at room temperature and should not be frozen or refrigerated. The product includes a quick guide on how to use the pen for self-injection. For further enquiries, an information line is available and the product is sold in a cleared sharps container. The text also includes dosage information and a caution to not use after the expiration date.*

FDA Label Image

Ai 1 mg 1 Pack Carton Label

Gvoke HypoPen is an auto-injector containing 1mg per 0.2mL of glucagon injection for subcutaneous use only. It is meant for low blood sugar emergencies and each package contains a single-dose auto-injector. The patient information should be consulted for complete instructions. The back panel of the package has a quick guide with instructions. The glucagon injection is stored in a sterile pouch and should be kept at room temperature between 27°C to 26°C. Gvoke HypoPen must not be used after its expiry date. For more information, experienced pharmacies can be contacted at 1-477-037-4737 or the Groke HypoPen website. The provided identification number is U-Z189EL 2N.*

FDA Label Image

Ai 1 mg 2 Pack Carton Label

Gvoke HypoPen 1mg per 0.2 mL is an injectable medication used for low blood sugar emergencies. It comes in a pack of two single-dose auto-injectors, intended for subcutaneous use only. The instructions can be found on the back panel of the package along with a quick guide. The Gvoke HypoPen should be stored at a controlled room temperature of 20°C to 26°C and should be disposed of after expiration and use. For more information, contact the pharmacy.*

FDA Label Image

Ai 1 mg Device Label

NDC 72065-121-11 is the identifier for the Gvoke HypoPen which is a glucagon injection used via a single-dose auto-injector. It is manufactured by Pyramid Laboratories and is intended for subcutaneous use only. The product appears to be associated with Yers Pharmaceuticals and is based in Chicago, L6060t.*

FDA Label Image

Ai 1 mg Pouch Label

This is a description of the Gvoke HypoPen, which is an auto-injector containing 1mg of glucagon for the treatment of low blood sugar emergencies. The injector is for subcutaneous use only and should be stored in a controlled room temperature before use. It comes in a sealed pouch and should be disposed of properly after use. The text provides step-by-step instructions on how to use the auto-injector. For more information, consumers can visit the website or call the manufacturer.*

FDA Label Image

Figure A

FDA Label Image

Figure B

FDA Label Image

Figure C

FDA Label Image

Figure D

FDA Label Image

Figure E

FDA Label Image

Figure F

FDA Label Image

Figure G

FDA Label Image

Figure H

FDA Label Image

Figure J

FDA Label Image

Figure K

FDA Label Image

Figure L

FDA Label Image

Figure M

FDA Label Image

Figure N

FDA Label Image

Figure O

FDA Label Image

Figure P

FDA Label Image

Figure Q

FDA Label Image

Full Image

The text describes the components of a medical product called Blue Cap, which includes a syringe needle, plunger body, needle cap, vial syringe, and a note emphasizing that each vial and syringe should only be used once and then disposed of. The purpose and context of Blue Cap are not provided.*

FDA Label Image

One Syringe Both Doses

This text suggests dosage recommendations for administration of a medication. The recommended dose for pediatric patients is 0.1 mL, while adults should receive a dose of 0.2 mL.*

FDA Label Image

Pfs 0.5 mg 1 Pack Carton Label

FDA Label Image

Pfs 0.5 mg 2 Pack Carton Label

Gvoke® PFS is a single-dose pre-filled syringe containing glucagon injection that is used for low blood sugar emergency. Each package contains 2 single-dose pre-filled syringes. The medication should be stored at room temperature and kept away from direct sunlight or heat. For more information, contact R-Jietd. The rest of the text may not be relevant or readable.*

FDA Label Image

Pfs 0.5 mg Device Label

This is a product label for "Gvoke PFS" which is a glucagon injection for subcutaneous use. It contains 0.5mg per 0.1mL and has NDC number 72065-130-11. No further information is available from the given text.*

FDA Label Image

Pfs 0.5 mg Pouch Label

FDA Label Image

Pfs 1 mg 1 Pack Carton Label

Gvoke® PFS is a pre-filled syringe containing 1mg of glucagon for subcutaneous use only in case of low blood sugar emergencies. The syringe contains a single dose and has a volume of 0.2 mL.*

FDA Label Image

Pfs 1 mg 2 Pack Carton Label

Gvoke® PFS is a glucagon injection used in case of low blood sugar emergency. Its package contains two single-dose pre-filled syringes for subcutaneous use. The medication comes with a quick guide instruction on the back panel. For more information, you can visit the Bharmscies heapids and TRV et VK SPFS website. The remaining text appears to be technical in nature, with indications on needle cap, needle finger flange, and viewing window/syringe body, among others.*

FDA Label Image

Pfs 1 mg Device Label

The text is describing a medication called Gvoke PFS, with the NDC number 72065-131-11. It is an injection containing 1mg of glucagon per 0.2mL and should only be used subcutaneously. There is also a reference to a PCl part number.*

FDA Label Image

Pfs 1 mg Pouch Label

Gvoke® PFS 1mg per 0.2 mL is a glucagon injection used for low blood sugar emergencies. The package includes a syringe, needle cap, finger flange, and viewing window. The instructions are to prepare, inject, and assist. For more information, visit www.GvokePFS.com or call 1-877-937-4737.*

FDA Label Image

Its Molecular Formula Is C153h225n43o49s With The Following Structure: (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

FDA Label Image

Figure 4 (Image 05)

FDA Label Image

Ai Image (Image 08)

FDA Label Image

Ifua-sideb-f1 (Image 09)

FDA Label Image

Ifua-sideb-f2 (Image 10)

FDA Label Image

Ifua-sideb-f3 (Image 11)

FDA Label Image

Ifua-sideb-f4 (Image 12)

FDA Label Image

Ifua-sideb-f5 (Image 13)

The text appears to be describing two different views, front and back, of an object or body part. There is a mention of exposing skin for an injection site, and there are two figures labeled as 5 and 6, but without any context it's impossible to determine what they depict.*

FDA Label Image

Ifua-sideb-f6 (Image 14)

This text seems to be describing a process that involves pushing and holding down a control button for 5 seconds until a click sound is heard, as represented by "Figure 8". However, the context or purpose of this process cannot be determined solely from this text.*

FDA Label Image

Ifua-sideb-f7 (Image 15)

FDA Label Image

Ifua-sideb-f8 (Image 16)

FDA Label Image

Ifua-sideb-f9 (Image 17)

FDA Label Image

Pfs Image (Image 20)

This text seems to be a collection of words and phrases related to medical or laboratory equipment. Specifically, it mentions a "NeedleCap" and a "Needle Finger Flange", as well as a "Plunger" and a "Viewing Window/Syringe Body". Without additional context or information, it is difficult to determine the exact purpose or use of these items.*

FDA Label Image

Ifub-sideb-f1 (Image 21)

FDA Label Image

Ifub-sideb-f2 (Image 22)

FDA Label Image

Ifub-sideb-f3 (Image 23)

FDA Label Image

Ifub-sideb-f4 (Image 24)

The text seems to describe two figures named "Figure 4" and "Figure 5". One figure shows a front view, while the other shows a back view. The text mentions exposing skin at the injection site. It is unclear what is being injected or why.*

FDA Label Image

Ifub-sideb-f5 (Image 25)

Not available.*

FDA Label Image

Ifub-sideb-f6 (Image 26)

FDA Label Image

Ifub-sideb-f7 (Image 27)

FDA Label Image

Ifub-sideb-f8 (Image 28)

This appears to be a caption to a figure or an illustration, and does not provide enough information to generate a useful description.*

FDA Label Image

Ifub-sideb-f9 (Image 29)

FDA Label Image

Kit Carton Side 1

FDA Label Image

Kit Carton Side 2

FDA Label Image

Pouch

This is a description of a single-dose sterile syringe that contains markings for 0.1 mL and 0.2 mL for subcutaneous use only, recommended dosage should refer to prescribing information. It can be used with Gvoke® vial only and should not be reused. The package does not contain latex and is non-pyrogenic. The syringe should not be removed from the pouch until time of use and should store vial and pouched syringe together. The product should not be used if the package is damaged or after the expiration date. There is an address in Chicago, IL for the manufacturer, but the name cannot be identified due to errors.*

FDA Label Image

Vial

The text describes the Gvoke® Kit R only, which is a product containing glucagon for injection. The product comes in a single-dose vial and should only be used subcutaneously. It is manufactured by Pyramid Laboratories for Xeris Pharmaceuticals located in Chicago, IL, and has an NDC code of 72065-141-11. The product label includes a lot number and expiration date, and users should discard any unused portion. The product should be protected from exposure to light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.